Latest news
Immune cell interaction timing impacts glioblastoma treatment response - News-MedicalNews-Medical · Mon, 10 Aug 2026 16:36:00 GMTVorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma - Science | AAASScience | AAAS · Wed, 05 Aug 2026 18:30:42 GMTSungkyunkwan University Team First to Show That Immune-Cell Timing Determines Glioblastoma Treatment Response | Newswise - NewswiseNewswise · Thu, 30 Jul 2026 12:25:00 GMT